2012, Number 1
<< Back Next >>
Rev Hematol Mex 2012; 13 (1)
Congenital hemophilia and chronic diseases in adults
Vargas RÁG
Language: Spanish
References: 55
Page: 16-24
PDF size: 95.03 Kb.
ABSTRACT
With the improved hemophilia treatments (mainly regular replacement therapy and prophylactic treatment with coagulation factor concentrates), in persons with hemophilia life expectancy is now approaching to the general male population. Patients often presents not only with the comorbidities typically associated with hemophilia (bleeding, arthropathy, blood-associated infections, among others), but also with age-related illnesses (such cancer and cardiovascular diseases). There are no evidence-based treatment guidelines of these conditions in hemophilia patients; the treatment is like their age-group peers without hemophilia.
REFERENCES
Rosendaal FR, Briet E, Stibbe J, van Herpen G, Leuven JA, et al. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol 1990;75(4):525-530.
Dolan G, Hermans C, Klamroth R, Madhok R, Schutgens RE, Spengler U. Challenges and controversies in haemophilia care in adulthood. Haemophilia 2009;15(Suppl 1):20-27.
Lim MY, Pruthi RK. Cardiovascular disease risk factors: prevalence and management in adult hemophilia patients. Blood Coagul Fibrinolysis 2011;22(5):402-406.
Stieltjes N, Calvez T, Demiguel V, Torchet MF, Briquel ME, et al. Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death. Haemophilia 2005;11(5):452-458.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28(12):1462-1536.
Sramek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003;362(9381):351-354.
Triemstra M, Rosendaal FR, Smit C, Van der Ploeg HM, Briet E. Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med 1995;123(11): 823-827.
Kulkarni R, Soucie JM, Evatt BL. Prevalence and risk factors for heart disease among males with hemophilia. Am J Hematol 2005;79(1):36-42.
Plug I, Van Der Bom JG, Peters M, Mauser-Bunschoten EP, De Goede-Bolder A, et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006; 4(3):510-516.
Sharathkumar AA, Soucie JM, Trawinski B, Greist A, Shapiro AD. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US). Haemophilia 2011;17(4):597-604.
Sramek A, Reiber JH, Gerrits WB, Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation 2001;104(7):762-767.
Foley CJ, Nichols L, Jeong K, Moore CG, Ragni MV. Coronary atherosclerosis and cardiovascular mortality in hemophilia. J Thromb Haemost 2010;8(1):208-211.
Mannucci PM, Schutgens RE, Santagostino E, Mauser- Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood 2009;114(26):5256-5263.
Schutgens RE, Tuinenburg A, Roosendaal G, Guyomi SH, Mauser-Bunschoten EP. Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline. Haemophilia 2009;15(4):952-958.
Mannucci PM, Mauser-Bunschoten EP. Cardiovascular disease in haemophilia patients: a contemporary issue. Haemophilia 2010;16 Suppl 3:58-66.
Coppola A, Tagliaferri A, Franchini M. The management of cardiovascular diseases in patients with hemophilia. Semin Thromb Hemost 2010;36(1):91-102.
Khorashadi S, Hasson NK, Cheung RC. Incidence of statin hepatotoxicity in patients with hepatitis C. Clin Gastroenterol Hepatol 2006;4(7):902-907; quiz 806.
Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC, Biesma DH, Schutgens RE. Cardiovascular disease in patients with hemophilia. J Thromb Haemost 2009;7(2):247-254.
Bovenzi F, De Luca L, Signore N, Fusco F, de Luca I. Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J 2003;4(10):728-730.
Mafrici A, Baudo F. Hemophilia and percutaneous coronary interventions. Ital Heart J 2003; 4(10): 731-733.
Stine KC, Becton DL. Use of factor VIII replacement during open heart surgery in a patient with haemophilia A. Haemophilia 2006;12(4):435-436.
Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B. Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 2006;116(2):120-125.
Batorova A, Martinowitz U. Continuous infusion of coagulation factors: current opinion. Curr Opin Hematol 2006;13(5):308-315.
Daniele F, Rossi V, Santoro C. Effective management of intracranial haemorrhage with continuous infusion of highly purified von Willebrand factor/factor VIII complex concentrate in an adult with severe haemophilia A. Blood Transfus 2011;9(4):472-474.
Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed). Chest 2008; 133(6 Suppl):546S-592S.
Tang M, Wierup P, Terp K, Ingerslev J, Sorensen B. Cardiac surgery in patients with haemophilia. Haemophilia 2009;15(1):101-107.
Vander Woude JC, Milam JD, Walker WE, Houchin DP, Weiland AP, Cooley DA. Cardiovascular surgery in patients with congenital plasma coagulopathies. Ann Thorac Surg 1988;46(3):283-288.
Ritchie B, Woodman RC, Poon MC. Deep venous thrombosis in hemophilia A. Am J Med 1992;93(6): 699-700.
Mannucci PM. Venous thromboembolism in von Willebrand disease. Thromb Haemost 2002;88(3):378-379.
Soucie JM, Nuss R, Evatt B, Abdelhak A, Cowan L, et al. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood 2000;96(2):437-442.
Beck P, Evans KT. Renal abnormalities in patients with haemophilia and Christmas disease. Clin Radiol 1972;23(3):349-354.
Benedik-Dolnicar M, Benedik M. Haematuria in patients with haemophilia and its influence on renal function and proteinuria. Haemophilia 2007;13(5):489-492.
Odabas AR, Cetinkaya R, Selcuk Y, Kaya H, Coskun U. Tranexamic- acid-induced acute renal cortical necrosis in a patient with haemophilia A. Nephrol Dial Transplant 2001;16(1):189-190.
Kulkarni R, Soucie JM, Evatt B. Renal disease among males with haemophilia. Haemophilia 2003;9(6): 703-710.
Fujii T, Takata N, Saito S, Naito T, Kimura A. Management of haemostasis during haemodialysis in a patient with haemophilia B. Haemophilia 2008;14(5):1135-1137.
Bajo MA, del Peso G, Jimenez V, Aguilera A, Villar A, Jimenez C, et al. Peritoneal dialysis is the therapy of choice for endstage renal disease patients with hereditary clotting disorders. Adv Perit Dial 2000;16:170-173.
Solak Y, Turkmen K, Atalay H, Turk S. Successful peritoneal dialysis in a hemophilia A patient with factor VIII inhibitor. Perit Dial Int 2010;30(1):114-116.
Lambing A, Kuriakose P, Lanzon J, Kachalsky E. Dialysis in the haemophilia patient: a practical approach to care. Haemophilia 2009;15(1):33-42.
Gomperts ED, Malekzadeh MH, Fine RN. Dialysis and renal transplant in a hemophiliac. Thromb Haemost 1981; 46(3):626-628.
El Bakkouri J, Mamdouh A, Faez S, Medkouri G, Ramdani B, Benchemsi N. [Kidney transplantation in a patient with haemophilia A]. Transfus Clin Biol 2009;16(5-6):471-473.
Majumdar S, Morris A, Gordon C, Kermode JC, Forsythe A, Herrington B et al. Alarmingly high prevalence of obesity in haemophilia in the state of Mississippi. Haemophilia 2010;16(3):455-459.
Hofstede FG, Fijnvandraat K, Plug I, Kamphuisen PW, Rosendaal FR, Peters M. Obesity: a new disaster for haemophilic patients? A nationwide survey. Haemophilia 2008; 14(5): 1035-1038.
Soucie JM, Cianfrini C, Janco RL, Kulkarni R, Hambleton J, Evatt B, et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood 2004;103(7):2467-2473.
Douma-van Riet DC, Engelbert RH, van Genderen FR, Ter Horst-De Ronde MT, de Goede-Bolder A, Hartman A. Physical fitness in children with haemophilia and the effect of overweight. Haemophilia 2009; 15(2):519-527.
Miesbach W, Alesci S, Krekeler S, Seifried E. Comorbidities and bleeding pattern in elderly haemophilia A patients. Haemophilia 2009;15(4):894-899.
Wallny TA, Scholz DT, Oldenburg J, Nicolay C, Ezziddin S, Pennekamp PH, et al. Osteoporosis in haemophilia - an underestimated comorbidity? Haemophilia 2007;13(1):79-84.
Khawaji M, Astermark J, Akesson K, Berntorp E. Physical activity for prevention of osteoporosis in patients with severe haemophilia on long-term prophylaxis. Haemophilia 2010;16(3):495-501.
Franchini M, Favaloro EJ, Lippi G. Hemophilia, cancer and cardiovascular disease. Blood Coagul Fibrinolysis 2010;21(1):1-2.
Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Rizza CR, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors’ Organisation. Lancet 1997; 350(9089): 1425-1431.
Ragni MV, Belle SH, Jaffe RA, Duerstein SL, Bass DC, McMillan CW et al. Acquired immunodeficiency syndrome-associated non-Hodgkin’s lymphomas and other malignancies in patients with hemophilia. Blood 1993; 81(7): 1889-1897.
Rejto L, Schlammadinger A, Ilonczai P, Tornai I, Batar P, Remenyi G, et al. Treatment of mantle cell lymphoma with autologous stem-cell transplantation in a patient with severe congenital haemophilia-A and chronic (B and C virus) hepatitis. Haemophilia 2010;16(4):706-707.
Ragni MV, Belle SH. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis 2001;183(7): 1112-1115.
Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 2009;136(1):138-148.
Meijer K, Haagsma EB. HCV-related liver cancer in people with haemophilia. Haemophilia 2011.
Zhang RF, Sun HQ, Huang Q, Wang JR, Zhang XX, Liu XN et al. Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia. Haemophilia 2010; 16(3): 502-7.